Late adverse events in patients with aggressive B-cell lymphoma after CD19-targeted chimeric antigen receptor T-cell therapy
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Camacho Arteaga, Lina
- Leguizamo Martinez, Lina Maria
- Filippi Arriaga, Francesca
- Iacoboni Garcia-Calvo, Gloria
- Alonso Martinez, Carla
- Vidal Guitart, Xavier
- Lopez Corral, Lucia
- Perez Lopez, Estefania
- Kwon, Mi
- Bailen Almorox, Rebeca
- Hernani Morales, Rafael
- Maiquez Asuero, Maria Pilar
- Barba Sunol, Pere
- Agusti Escasany, Antonia
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Camacho,L,Leguizamo,LM,Filippi,F,Iacoboni Garcia,G,Alonso,C,Vidal,X,Lopez,L et al. Late adverse events in patients with aggressive B-cell lymphoma after CD19-targeted chimeric antigen receptor T-cell therapy. 111 RIVER ST, HOBOKEN 07030-5774, NJ:WILEY. 2022 p.p. 22-22.
Portal de investigación